Record-Breaking Volumes, Cutting-Edge Tech
Published: 2025-07-02 15:37

According to data from the National Cancer Center, esophageal, gastric, and colorectal cancers account for 43.3% of all cancer cases in China, making them the three most prevalent digestive tract malignancies.

 

In 2024, Renji Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, set a new record by performing over 300,000 digestive endoscopy procedures—a testament to both the rising incidence of digestive cancers and growing public awareness of early detection.

 

Renji Hospital's Endoscopy Center, building on the strengths of its renowned Gastroenterology Department, has developed distinctive expertise in:

 

● Early detection and treatment of digestive tract tumors

● Small intestine diseases

● Gastrointestinal bleeding management

 

In recent years, the center has introduced a range of advanced procedures:

Standard and painless gastroscopy/colonoscopy.

 

● Capsule endoscopy (pill-sized camera for small bowel imaging)

● Double-balloon enteroscopy (for deep small intestine examination)

● Magnifying endoscopy (high-definition microscopic views)

● Confocal laser endomicroscopy (real-time cellular-level imaging)

● Endoscopic ultrasound (EUS)

● ERCP (for bile/pancreatic duct disorders)

● Tumor removal techniques (ESD/EMR)

● POEM (non-surgical treatment for swallowing disorders)

● Stent placement (for narrowed digestive passages)

● Emergency bleeding control

● Foreign object removal

 

These innovations have significantly:

● Improved diagnostic accuracy

● Shortened procedure times

Enhanced patient recovery experiences



 

"We're committed to making advanced endoscopy both precise and patient-friendly," says the center's director Dr. Xiaobo Li, “The center will actively continue collaborating with global medical institutions to adopt international best practices, ensuring patients receive world-class care.”


Prev: International Guidelines Set for Revision! Groundbreaking Chinese Gastroenterology Research Published in NEJM
Next: Chinese Scientists Make a Major Discovery: Novel Using Traditional Medications Berberine to Reduce the Risk of Colorectal Adenoma Recurrence Even 6 Years After Withdrawal